tiprankstipranks
Galectin Therapeutics Inc (GALT)
NASDAQ:GALT
US Market
GALT
Galectin Therapeutics
RESEARCH TOOLSreports
Want to see GALT full AI Analyst Report?

Galectin Therapeutics (GALT) Ownership - Who Owns Galectin Therapeutics?

682 Followers

Galectin Therapeutics (GALT) Ownership Overview

51.09%2.55%2.32%4.27%39.77%
51.09% Insiders
2.55% Mutual Funds
2.32% Other Institutional Investors
4.27% ETFs
39.77% Public Companies and
Individual Investors
The ownership structure of Galectin Therapeutics (GALT) stock is a mix of institutional, retail, and individual investors. Approximately 9.14% of the company’s stock is owned by Institutional Investors, 51.09% is owned by Insiders, and 39.77% is owned by Public Companies and Individual Investors.
The ownership structure of Galectin Therapeutics (GALT) stock is a mix of institutional, retail, and individual investors. Approximately 4.87% of the company’s stock is owned by Institutional Investors, 51.09% is owned by Insiders, and 4.27% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Feb 09, 2026
Kary Eldred
xxxxxxxxxxxxx
$810
Jan 13, 2026
Joel Lewis
xxxxxxxxxxxxx
$218568
Dec 23, 2025
Kary Eldred
xxxxxxxxxxxxx
$2611
Dec 23, 2025
Kevin D. Freeman
xxxxxxxxxxxxx
$19470
Show More Insider Trading Activity >

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
44,741,553Insider44.36%185,230,029
5,614,457Insider5.57%23,243,852
2,463,582Institution2.44%10,199,229
1,915,073Institution1.90%7,928,402
1,672,744Institution1.66%6,925,160
778,260Insider0.77%3,221,996
536,264Institution0.53%2,220,133
137,269Insider0.14%568,294
70,107Insider0.07%290,243
66,769Insider0.07%276,424

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,915,073Institution1.90%7,928,402
536,264Institution0.53%2,220,133
29,970Institution0.03%124,076
26,902Institution0.03%111,374
24,567Institution0.02%101,707
22,865Institution0.02%94,661
7,750Institution<0.01%32,085
5,212Institution<0.01%21,578
1,086Institution<0.01%4,496
289Institution<0.01%1,196

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
Vanguard
1,521,443Institution1.51%4,518,686
iShares
1,044,133Institution1.04%4,322,711
Vanguard
618,821Institution0.61%1,837,898
iShares
308,290Institution0.31%1,276,321
Vanguard
269,980Institution0.27%801,841
iShares
165,385Institution0.16%684,694
iShares
154,680Institution0.15%640,375
Horizon Kinetics
42,452Institution0.04%195,704
Vanguard
35,669Institution0.04%105,937
SPDR
24,004Institution0.02%107,538

FAQ

Who Owns Galectin Therapeutics Inc (GALT)?
According to the latest TipRanks data, approximately 2.32% of the company's stock is held by institutional investors, 51.09% is held by insiders, and 39.77% is held by retail investors.
    What percentage of Galectin Therapeutics Inc (GALT) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 2.32% of Galectin Therapeutics Inc (GALT) stock is held by institutional investors.
      What percentage of Galectin Therapeutics Inc (GALT) stock is held by retail investors?
      According to the latest TipRanks data, approximately 39.77% of Galectin Therapeutics Inc (GALT) stock is held by retail investors.
        Who owns the most shares of Galectin Therapeutics Inc (GALT)?
        Richard E Uihlein owns the most shares of Galectin Therapeutics Inc (GALT).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.